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1. Introduction 
Activation of the classical pathway of complement 
proceeds sequentially through activation of Cl and 
assembly of the C3 and C5 convertases [ 11. The C3 
convertase is a complex of equimolar amounts of C4b 
and C2a formed upon limited proteolysis of C4 and 
C2 by Ci. C2 cleavage by Ci may be a limiting step 
in the activation of complement as it occurs when C2 
is on or in close proximity to C4b bound to an accep- 
tor [I]. 
the methods in [2-61 with several improvements 
leading to a simplified preparation and a high yield of 
purified C2. 
2. Materials and methods 
Little is known about the detailed mechanism of 
CT-C2 interaction. Ci active site is located in sub- 
component Cis, which is likely to behave differently 
in soluble or particulate Ci. The purpose of this 
paper is to study the cleavage of C2 by isolated Cis 
or by different associations reconstructed from indi- 
vidual subcomponents: Cir,-Cis, and two different 
forms of Cl. Kinetic parameters for these interactions 
between soluble molecules are reported, as a refer- 
ence for further studies on particulate components. 
Human titrated plasma was obtained from the 
Centre de Transfusion Sanguine (Grenoble). 
DFP was from Sigma. Sheep erythrocytes were 
purchased from Bio-Merieux. Hemolysin and antisera 
to factor B, haemopexin, albumin, C3, C4, C5, IgG 
were from Behring. Antiserum to human serum was 
purchased from ICL Scientific. Antisera to human 
IgM, CT Inh, Cl q, Cir, Cis, C4bp were prepared in 
our laboratory. Lactoperoxidase (purified grade) was 
purchased from Calbiochem. Na’2SI (spec. act. 2 Ci/ 
E.tmol), and 1251-labelled Bolton and Hunter reagent 
(spec. act. 2 Ci/pmol) were from the Radiochemical 
Centre (Amersham). Other chemicals were of analyti- 
cal grade. 
For this purpose C2 purification has been reinves- 
tigated and a new protocol established: it is based on 
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Proteins were estimated according to [7], using 
bovine serum albumin as a reference. Purified C2 was 
estimated from its A 280, assuming Ei 2m = 10.0. 
C2 haemolytic activity was measured as in [ 8] 
and was expressed in 5% lysis units X no. erythro- 
cytes/ml. 
SDS-PAGE and staining of proteins with Coomassie 
blue were done as in [9,10]. 
N-Terminal amino acids were identified by dan- 
sylation [ 1 l] and thin-layer chromatography [ 121. 
Sucrose gradient ultracentrifugation was done as 
in [13]. 
Clq, Cir and Cis were purified as in [ 141. Pro- 
enzymic C 1 r was purified as in [ 151 and proenzymic 
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Cls as in [ 161. Cl subcomponents were estimated 
from their Asso, using respectively f$$.,., = 11.5 for 
Cis and Cls [17], 9.5 for Cir and Clr [17] and 6.85 
for Clq [18]. 
C4 was purified as in [ 191 and estimated from its 
A 280, using E:‘& = 10.0 [20]. C4b-like C4 was pre- 
pared by incubating purified C4 in 6 M urea, 100 mM 
NaCl, 100 mM NaHCOs (pH 8.1) for 15 min at 0°C 
followed by overnight dialysis against the same buffer 
without urea. C4b was obtained by incubation of C4 
and Cis for 60 min at 37’C at a 50: 1 (w/w) ratio, in 
150 mM NaCl, 5 mM EDTA, 20 mM phosphate 
(pH 7.4), followed by treatment with 5 mM DFP for 
30 min at 37°C. C4b-Sepharose was prepared by cou- 
pling 50 mg C4b to 30 ml CNBr-activated Sepharose 
4B [21]. The same protocol was used for the prepara- 
tion of C4-Sepharose and C4b-like C4-Sepharose. 
‘251-Labelling of proteins followed [22] or was by 
lactoperoxidase catalysis as in [20]. The average iodine 
binding was between 0.04-0.06 mol 1251/mol C2. 
C2 cleavage by Cis was measured at 37’C using 
various dilutions of r2’I-labelled C2 in a buffer con- 
taining 5 mM TEA-HCl, 145 mM NaCl and 1 mg egg 
albumin/ml (pH 7.4). The amount of Cis was chosen 
in order to cleave 20-40% of C2 in 10 min. At regu- 
lar time intervals, samples were removed, immediately 
reduced with 50 mM dithiothreitol for 5 min at 
lOO”C, alkylated by 140 mM iodoacetamide for 
20 mm at 37°C then submitted to SDS-PAGE. Gels 
were cut into 1 mm slices and counted for radioactiv- 
ity in a MR 480 Kontron y-counter. 
3. Results 
3.1. Atrification of C2 
3 .l .l . Treatment of plasma with inhibitors 
Frozen, titrated plasma was thawed and incubated 
for 30 mm at 20°C with 5 mM DFP, 2 mM EDTA 
and 0.01% (v/v) 2-mercaptoethanol, then adjusted to 
pH 6.0 with acetic acid. All subsequent operations 
were done at 4’C. 
3.1.2. (NH4)2S04 precipitation 
(NH4)2S04 was added to the plasma to 2.2 M final 
cont.; the mixture was stirred for 60 min and centri- 
fuged for 30 min at 23 000 X g. A second addition of 
(NH4)2S04 was made to the supernatant to 3.3 M 
final cont. After 60 min stirring the precipitate was 
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collected by centrifugation for 30 min at 23 000 X g. 
The pellet was then redissolved in 100 ml 50 mM 
sodium acetate (pH 6.0) containing 2 mM EDTA, 
5 mM DFP and 0.01% (v/v) 2-mercaptoethanol, and 
dialysed overnight against the same buffer. 
3 .I .3. Chromatography on CM52cellulose 
After dialysis, the fraction was diluted to a con- 
ductivity of 2.85 mS (at 4OC) and applied to a col- 
umn of CM52-cellulose (2.75 X 42 cm) equilibrated 
in 50 mM sodium acetate buffer (pH 6.0) containing 
2 mM EDTA and 0.01% (v/v) 2-mercaptoethanol. The 
column was washed with this buffer until the A280 of 
the eluate was <0.05. Elution was carried out with a 
linear NaCl gradient (O-l 50 mM) in the same buffer 
(total vol. 1400 ml). C2 was detected in the eluate by 
haemolytic assay and the active fractions were pooled 
in the presence of 5 mM DFP. After concentration by 
ultrafiltration on PM 10 (Amicon), the pH was raised 
to 8.5 with Tris-base 1 M and the pool was dialysed 
against 125 mM NaCl, 2 mM MgC12, 20 mM Tris-HCI 
(pH 8.5). 
3.1.4. Affinity chromatography on C4b-Sepharose 
The dialysed fraction was applied to a column of 
C4b-Sepharose equilibrated in the dialysis buffer 
containing 0.01% (v/v) 2-mercaptoethanol. The col- 
umn was washed with 300 ml of this buffer. C2 was 
eluted with 150 mM NaCl, 10 mM EDTA and 50 mM 
sodium acetate (pH 6.5). Purified C2 was pooled and 
concentrated by ultrafiltration on PM 10 in the pres- 
ence of 5 mM DFP. 
A typical purification is illustrated in table 1. The 
final yield of C2 is -40% with a purification factor 
of 5000. 
Purified C2 appears as a single polypeptide chain 
of app. Mr 95 000 on SDS-PAGE under reducing or 
non-reducing conditions (fig.1). The control by dou- 
ble immunodiffusion in agarose was negative with 
antisera to factor B, haemopexin, IgG, IgM, albumin, 
C3, C4, C5, C4-binding protein, CiInh, Clq, Cir and 
Cis; using antiserum to whole human serum only one 
precipitin line was detected. 
3.2. Determination of the enzymic constants for the 
cleavage of C2 by Cis 
3.2.1. Cleavage of C2 by isolated Cis 
Incubation of C2 with catalytic amounts of Cis 
(C2:Cis = 5000: 1) (w/w) resulted in cleavage of C2 
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Table 1 
C2 purification 
May 1982 
Fraction 
Plasma 
Ammonium sul- 
phate precipitatea 
CM 52 eluateb 
C4b-Sepharoseb 
eluate 
Vol. Total act. 
(ml) (10’3 units) 
500 10.6 
585 9.8 
44 5.5 
3 4.2 
Total pro- 
tein (mg) 
31 500.0 
13 455.0 
43.6 
2.5 
Spec. act. 
(10” units/mg) 
0.034 
0.073 
12.700 
168.000 
Purifica- Yield 
tion factor (%) 
1.0 100.0 
2.2 92.7 
378.0 52.2 
5000.0 39.2 
a Determinations made after dialysis and dilution of the extract 
b Determinations on concentrated fractions 
into two fragments, C2a and C2b of app. M, 68 000 
and 28 500 (fig.2). No other products were detected 
on SDS-PAGE after incubation of C2 with Cis in a 
10: 1 (w/w) ratio for <60 min. 
N-terminal amino acid analysis of Cis-cleaved C2 
revealed alanine (N-terminal residue of C2b) and 
lysine (N-terminal residue of C2a) as in [23]. 
C2 cleavage by Cis was followed as in section 2. 
The decrease of radioactivity in C2 was equal to the 
amount of radioactivity appearing in C2a and C2b. 
The initial velocity of the cleavage was calculated for 
each C2 concentration and the data treated according 
to [24]. 
The Lineweaver-Burk plots of the reaction in the 
Fig.1. SDS-PAGE of purified C2. Electrophoresis was done 
as in section 2: 18 pg protein were applied to each gel - (1) 
unreduced C2; (2) reduced and alkylated C2. 
Fig.2. Kinetic analysis by SDS-PAGE of C2 cleavage by Cis: 
140 pg C2 in 200 ~1 145 mM NaCl, 5 mM CaC$5 mM TEA- 
HCl (pH 7.4) were incubated with 0.028 pg Cls at 37°C. Ali- 
quots (30 ~1) were removed at different times, immediately 
reduced, alkylated and analysed by SDS-PAGE as in section 2. 
21 
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Fig.3. Lineweaver-Burk plot of C2 cleavage by Cis and by 
CT;,-Cis,: “’ I-labelled C2 at 1.5-5.9 X 10e6 M was prote- 
olysed either by Cis (1.95 X low9 M) in the presence of 5 mM 
EDTA (o), 5 mM CaCl, (o), or by Cir,-Cis, (Cir:cis = 1: 1) 
(w/w) (A). So and V, values were obtained as in [ 24 1. 
presence of 5 mM EDTA or 5 mM CaClz are depicted 
in fig.3 and the kinetic constants of the reactions 
reported in table 2. They are not significantly influ- 
enced by the dimerisation of Cis induced by calcium. 
Fig.4. Lineweaver-Burk plot of C2 cleavage by CT: 1251-label- 
ledC2atl.l-5.2 X 10-6MwascleavedbyCis(1.95 X 10e9 M) 
in ‘hybrid Ci’ (0) of by Cis in CT reconstituted from Clq, 
Clr, Cls and subsequently activated; Cis was: 9.1 X 10e9 M 
(a); 13.6 X 10e9 M (0); 18.2 x 10m9 M (0). So and V, values 
were obtained as in [ 241. 
3.2.2. Cleavage of C2 by Cis in the Cir,-Cis, 3.2.3. Cleavage of C2 by Cis in Ci reassembled from 
association 
The Ci&Ci& association was obtained by incu- 
bation of Cir and Cis in a 1: 1 or 2: 1 (w/w) ratio for 
30 min at 30°C in the presence of 5 mM CaCl*. Con- 
trol by sucrose gradient ultracentrifugation showed 
that in both cases Cis was entirely incorporated in a 
ci;,-Cis2 tetrameric association, as in [25]. The 
association of Cir with Cis induces a slight decrease 
of Kn, and V, of the reaction (fig.3, table 2). Excess 
of Clr was without effect on these parameters. 
C 1 q, proenzymic C 1 r and activated Cis 
‘Hybrid Ci’ [26] was reconstructed in the presence 
of 5 mM CaClz from a mixture of Cl q, proenzymic 
Clr and activated Cis in a 2.5: 1: 1 (by wt) ratio. Con- 
trol by ultracentrifugation on sucrose gradient showed 
a major peak at 15.2 S corresponding to Ci and con- 
taining (-90% of the total Cis enzymatic activity. No 
significant difference in the Km of the reaction, and a 
5-6fold reduction of the V, was shown in compari- 
son with results reported for isolated Cis (fig.4, table 2). 
l/SO( 10_5M) 
Table 2 
Catalytic constants of the cleavage of C2 by Cis 
ct form [cis] 
(lo+ M) 
Km 
(lo+’ M) 
vm 
(lo-’ mol/min) 
Mol C2 cleaved . mol 
cis-1 . min-’ 
Cis (5 mM EDTA) 
Cis (5 mM CaCl,) 
cir,-cis 
l-6 
5 mM CaCl), 
‘Hybrid’ Cl (5 mM CaCl,) 
CiC (5 mM CaCl,) 
1.95 34.1a 21.1a 1082a 
1.95 19.7a 19.7a 1013a 
1.95 15.0a 15.4a 747a 
1.95 23.8 3.1 160 
9.1 2.5 0.6 6.5 
13.6 2.7 1.4 10.5 
18.2 2.8 2.0 11.0 
a Mean values 
b Reassembled from Clq, proenzymic Clr and activated Cls 
’ Reassembled for Clq, proenzymic Clr and proenzymic Cls, then activated 
22 
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3.2.4. Cleavage of C2 by Cis in Ci reassembled from 
Clq, Clr and Cls and subsequently activated 
Cl was reconstructed in the presence of 5 mM 
CaCl, from a mixture of Clq, proenzymic Clr and 
proenzymic Cls in a 2.5: 1: 1 (by wt) ratio, and subse- 
quently activated by incubation for 30 min at 37°C. 
Control by sucrose gradient ultracentrifugation 
showed that -50% of the Cis activity was in the 
15.2 S peak of CT. Fig.4 and table 2 indicate a signifi- 
cant decrease of the Km of the proteolytic reaction 
(-1: 10 of the Km of ‘hybrid CT’); also no. mol C2 
cleaved . mol Cls-’ min-’ is, respectively, lOO- and 
16times less than with isolated Cis and ‘hybrid CT’. 
4. Discussion 
This protocol for C2 purification is characterized 
by a high yield (40% from plasma) and the absence of 
contaminants (one precipitin line with antiserum to 
whole human serum); no cleavage of C2 was observed 
upon incubation for 1 h at 37’C. Purified C2 wasvery 
stable and could be stored at 0°C for several months 
without detectable loss of activity; in contrast freezing 
and thawing led to significant drop in C2 haemolytic 
activity. 
Particular attention was given to the affinity chro- 
matography step in the purification, due to a specific 
(Mg*+-dependent) and a non-specific interaction 
between C2 and C4b-Sepharose; a moderate ionic 
strength was chosen in order to get rid of a maximum 
of contaminants perfusing through the column. C4b- 
like C4 and C4 bound to Sepharose were less efficient 
than C4b for C2 binding. 
Kinetic parameters were established with 1251-label- 
led C2 prepared with the Bolton and Hunter reagent, 
as lactoperoxidase-catalyzed iodination of C2 impaired 
its cleavage by Cis and its haemolytic activity. Inocu- 
ity of the iodination was established in parallel exper- 
iments using unlabelled C2. 
The estimate of V, and Km for the proteolysis of 
C2 by Cis shows that the calcium-dependent dimerisa- 
tion of Cis does not significantly alter these parame- 
ters. When Cis is incorporated in a calcium-dependent 
Cir2-Cis, tetrameric association the turnover num- 
ber of C2 is moderately reduced. The most evident 
effect is observed when Cls is associated with Clr 
and Cl q in Cl before activation, with a net decrease 
of the Km and of the turnover number of C2. When 
activated Cis is incorporated in ‘hybrid Ci', together 
with Clq and proenzymic Clr, only a decrease of the 
turnover number of C2 is found. These results show 
that maximum affinity for C2 is exhibited by Cis 
activated inside Cl. Studies on C2 proteolysis by CT 
were reported in [27] and similar Km values for C4 
and C2 concluded. No differences in Km and turnover 
numbers for the proteolysis of C4 by Cis and Ci 
were detected in [28]; the value of Km reported is in 
the same order of the value we found for Ci recon- 
structed in its proenzymic form before activation. 
These kinetic data are likely to reveal additional 
information on Cl structure to results obtained by sur- 
face iodination [25,26]. They also indicate that for a 
physiological concentration of C2 (1.2 X lob7 M, 
[28]) cleavage of C2 is probably very inefficient unless 
C2 is ‘presented’ to Ci in an optimal position defined 
by C4b. 
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